e-learning
resources
Stockholm 2007
Sunday 16.09.2007
New insights into clinical lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ribavirin therapy for respiratory syncitial virus infection after lung transplantation
F. Bini, A. Cascina, F. Meloni, C. Lastoria, T. Oggionni (Pavia, Italy)
Source:
Annual Congress 2007 - New insights into clinical lung transplantation
Session:
New insights into clinical lung transplantation
Session type:
Electronic Poster Discussion
Number:
334
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bini, A. Cascina, F. Meloni, C. Lastoria, T. Oggionni (Pavia, Italy). Ribavirin therapy for respiratory syncitial virus infection after lung transplantation. Eur Respir J 2007; 30: Suppl. 51, 334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Respiratory syncytial viral infections in lung transplant recipients: Treatment with aerolised ribavirin
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Inhaled and small molecules therapeutics to fight respiratory syncytial virus infection in newborn lung
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Year: 2019
Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 169s
Year: 2001
Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity
Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Year: 2006
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants
Source: Eur Respir J 2014; 44: 666-674
Year: 2014
Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections
Source: Eur Respir J 2013; 42: 461-469
Year: 2013
Respiratory infections in children: from respiratory syncytial virus to tuberculosis
Source: International Congress 2019 – Paediatric Year in review
Year: 2019
Respiratory syncytial virus (RSV) prophylaxis in special populations
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011
Prophylaxis against respiratory syncytial virus in high-risk infants
Source: Eur Respir Monogr 2021; 92: 361-371
Year: 2021
Nebulised therapy in pregnants with acute respiratory virus infections (ARVI)
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Prevalence of respiratory syncytial virus infection among Philippino children with bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Interleukin-9 in severe respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
A single-season prospective study of respiratory viral infections in lung transplant recipients
Source: Eur Respir J 2006; 28: 131-137
Year: 2006
DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2001; 18: 734-737
Year: 2001
Rhinovirus infections in infants: is respiratory syncytial virus ready for the challenge?
Source: Eur Respir J 2008; 32: 249-251
Year: 2008
Respiratory syncytial virus: types and genotypes of the virus in infants hospitalized with lower respiratory tract infection in Brazil
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005
Prevalence of bacterial infection in children with documented respiratory syncytial virus lower respiratory tract infection
Source: ISSN=ISSN 1810-6838, ISBN=, page=53
Year: 2004
The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept